论文部分内容阅读
在骨骼肉瘤的外科治疗中,经过多次改革,结合使用化疗、放疗后,预后有很大的改善。截肢已不再悬唯一的手术手段,而进入挽救肢体的时代。目前之所以能取得这样良好的效果,是由于恰当进行各种辅助治疗。在化疗、放疗和免疗的保护下,使肢体的保留得以成为现实。我们称这些疗法为辅助治疗,是因为它们还不能代替外科手术,而是做为治疗骨骼肿瘤的不可缺少的环节。因此,有一个新的问题被提出来,就是手术的时间和范围。
In the surgical treatment of skeletal sarcoma, after several reforms, combined with chemotherapy, radiotherapy, the prognosis has greatly improved. Amputation is no longer the only surgical method to save the limbs. The reason why such a good effect can be achieved at present is that various kinds of adjuvant therapy are properly performed. Under the protection of chemotherapy, radiotherapy and no therapy, the retention of limbs becomes a reality. We call these therapies as adjunctive treatments because they are not yet an alternative to surgery but are an indispensable part of the treatment of skeletal tumors. Therefore, there is a new issue that is raised, that is, the time and scope of the surgery.